Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharma Equity Group
Hørsholm, Denmarkpharmaequitygroup.com ↗
- Ownership
- Public · PEG
- Development stage
- Other
01
Overview
The company’s main subsidiary, Reponex Pharmaceuticals, has multiple candidates in Phase II clinical trials targeting serious inflammatory diseases and colorectal cancer. No commercial products yet; all programs are in the clinical development phase.
- Therapeutic areas
- DermatologyGastroenterologyOncologyInfectious Diseases
- Modalities
- Small moleculeDrug delivery system
- Industry
- Biotech
02
Partnerships
Collaborations with academic institutions and research organizations are mentioned but not named specifically. Strategic partnerships sought for late-stage/commercialization phases.
03
Financials
- Market cap
- $12.5M
- Total revenue
- $0
- Enterprise value
- $14.1M
Beyond the preview
Go deeper on Pharma Equity Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharma Equity Group.